Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Endogenous pancreatic polypeptide in different vascular beds: relationship to release and degradation in subjects with normal and decreased kidney function

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Abnormal levels of adipokines in adolescent offspring of women with type 1 diabetes - Results from the EPICOM study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI)

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vagotomy and subsequent development of diabetes - A nested case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: a functional GLP-1-renal axis in man

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An acoustic myography functional assessment of cerebral palsy subjects compared to healthy controls during physical exercise

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The plasma concentration of pancreatic polypeptide (PP-like immunoreactivity) was measured in different vascular beds in order to determine regional kinetics of endogenous PP in fasting, supine subjects with normal or moderately decreased kidney function. Patients with kidney disease (n = 10) had a significantly higher level of circulating PP than controls (n = 10): median PP = 52 (range 21 to 352) v 20 (6 to 143) pmol/L, respectively (P less than 0.02). Circulating PP was inversely correlated to 51Cr-EDTA plasma clearance (r = -0.57, P less than 0.02, n = 14) and directly correlated to serum creatinine concentration (r = 0.70, P less than 0.01). Hepatic venous PP was significantly higher than systemic PP in both controls and patients with kidney disease (P less than 0.001, n = 15). The values were positively correlated (r = 0.98, P less than 0.001; slope = 1.37 +/- 0.05, P less than 0.001), indicating a progressively increasing rate of PP secretion in subjects with raised circulating PP. No statistically significant difference could be detected between systemic and renal venous PP or across the lung, left adrenal gland, or lower limb. Assuming steady state between secretion and biodegradation, the metabolic clearance rate of the peptide was estimated to be approximately 600 to 800 mL/min in controls and slightly below this value in patients with nephropathy. These results suggest that the raised circulating PP found in patients with decreased kidney function is due to both increased secretion and decreased degradation.(ABSTRACT TRUNCATED AT 250 WORDS)
Original languageEnglish
JournalMetabolism
Volume35
Issue number6
Pages (from-to)542-6
Number of pages5
ISSN0026-0495
Publication statusPublished - Jun 1986

    Research areas

  • Adult, Aged, Arteries, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Kinetics, Male, Middle Aged, Pancreatic Polypeptide, Veins

ID: 39027682